SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 36.21 |
| Enterprise Value ($M) | 25.73 |
| Book Value ($M) | -5.05 |
| Book Value / Share | -0.05 |
| Price / Book | -7.17 |
| NCAV ($M) | -8.79 |
| NCAV / Share | -0.09 |
| Price / NCAV | -4.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.95 |
| Return on Equity (ROE) | -5.81 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.86 |
| Current Ratio | 0.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 17.54 |
| Assets | 21.28 |
| Liabilities | 26.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.81 |
| Operating Income | -30.74 |
| Net Income | -30.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -38.86 |
| Cash from Investing | -0.63 |
| Cash from Financing | 15.64 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 277,046 | 854,925 | 32.41 | |
| 492,461 | 2,186,456 | 22.52 | |
| 121,205 | 18,884 | 641.84 | |
| 52,185 | 181,285 | 28.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYCN – Cyclerion Therapeutics, Inc. | CYRX – Cryoport, Inc. |
| CYTH – Cyclo Therapeutics, Inc. | DERM – Journey Medical Corporation |
| DMAC – DiaMedica Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io